Navigation Links
Bioniche Reports Fiscal 2009 Year-End Results
Date:9/18/2009

       - revenues increase by 21% over Fiscal 2008, to $33.3 million -

    (all figures are in Canadian dollars unless otherwise noted)

BELLEVILLE, ON, Sept. 18 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its 2009 fiscal year ended June 30, 2009.

"We had a very successful year in terms of revenues generated by our base Animal Health business, experiencing 21% growth in a challenging global economy," said Graeme McRae, Chairman, President CEO of Bioniche Life Sciences Inc. "In addition, subsequent to the end of the fiscal year, we announced a transformative corporate event: The signing of a licensing agreement with Endo Pharmaceuticals Inc. for exclusive rights to develop and market UrocidinTM in the U.S. with an option for global rights."

Urocidin is a patented formulation of Mycobacterial Cell Wall-DNA Complex (MCC) developed by Bioniche for the treatment of non-muscle-invasive bladder cancer that is currently undergoing Phase III clinical testing.

Subsequent to the year-end, the Company received an up-front payment of US$20 million from Endo and executed a series of transactions improving its capital structure. At present, the Company reports that its unaudited cash position, inclusive of restricted cash, at the end of August, 2009, was $16.6 million. This strong cash position is the net result of the closing of the License, Development and Supply Agreement as explained above, the repayment of the revolving credit facility and associated fees of $6.2M (US$5.3M), the sale of U.S. licensing rights to a product in the animal health market subsequent to June 30, 2009 for $0.9M (US$0.8M), fourth quarter working capital variations, and repayment of overdue outstanding payables. More information on the partnership transaction and other subsequent events is provided
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Bioniche Phase III Clinical Trial with Urocidin(TM) Given Continued Green Light by DMC
2. Bioniche Repays Revolving Credit Facility
3. Bioniche Provides a Corporate Update
4. Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection
5. Bioniche Represented at House of Commons Sub-Committee on Food Safety
6. Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well
7. Bioniche Reports Fiscal 2009 Third Quarter
8. Bioniche Provides a Corporate Update
9. Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM)
10. Bioniche Revolving Credit Facility Maturity Date Amended
11. Bioniche Phase II Bladder Cancer Trial Results Published in The Journal of Urology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... Texas (PRWEB) October 20, 2014 ... development for Partial Seizure, complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ... featured news and press releases. It also reviews ... Partial Seizure and special features on late-stage and ...
(Date:10/19/2014)... Recently, Top10BestSEOHosting.com has unveiled its newest ... and HostMonster are the best VPS hosting suppliers ... is the method of partitioning a physical server ... the appearance and capabilities of running on someone’s ... pays close attention to VPS products and related ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 SweetDressy.com, a ... recently announced its promotion for long evening dresses ... enjoy the special offer; the current discount is up ... of the industry pioneers in the fashion field. Its ... for ladies dwelling in various parts of the world. ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 Stephen T. Greenberg, ... been nominated for the 10th consecutive year as one of ... Dr. Greenberg was also been nominated as the best provider ... also nominated as best Day Spa and best Laser Treatment ... December 14th and readers can vote for the contest once ...
(Date:10/19/2014)... is a systemic disease that causes inflammation in ... affected members of the ancient Egyptian royal families. ... & Rheumatology , a journal of the American ... instead a degenerative spinal condition called diffuse idiopathic ... the 18th to early 20th Dynasties. , ...
Breaking Medicine News(10 mins):Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2Health News:Mummy remains refute antiquity of ankylosing spondylitis 2
... A new $10 million research project which aims at ... launched by the Preventative Health //Flagship, a CSIRO program ... on the early detection of Alzheimer's disease, which currently ... researchers will be using Positron Emission Tomography (PET scans) ...
... screening appears to be increasing among Veterans Affairs patients, ... screening procedures// , according to a report. A second ... with other illnesses and reduced life expectancies may not ... harmed, but continue to be screened at high rates. ...
... have come up with incriminating evidence that warns non-vegetarians who ... study has pointed out that eating more than one and ... developing hormone related breast cancer and another study that ... heart from heart diseases except for vitamin C which seems ...
... the remedy of choice for treatment of influenza is causing ... side effects, regulators said today. ,The U.S. FDA has ... and mental disorientation were reported from Japan by people who ... reports concerned children. ,The new label approved by ...
... patients will adhere more closely to their medication regimens ... care program that includes patient education, specially packaged medications, ... ,The “Federal Study of Adherence to Medications in the ... Health-System Pharmacists (ASHP) Research and Education Foundation, followed 200 ...
... onset of diabetes today is linked to high stress levels. ... diet, hypertension and lack of physical exercise. The number of ... crores and about 7.2 lakh lives are claimed by this ... realize consequences of this deadly disease. , ,Because ...
Cached Medicine News:Health News:Studies Examine Colorectal Cancer Screening Rates 2Health News:Studies Examine Colorectal Cancer Screening Rates 3Health News:Studies Examine Colorectal Cancer Screening Rates 4Health News:Red alert to women against red meat consumption 2Health News:Caution:Tamiflu ‘tames’ flu but psychiatric side effects now report 2Health News:Pharmacy Care Program Can Increase Medication Adherence in Elderly 2Health News:Pharmacy Care Program Can Increase Medication Adherence in Elderly 3Health News:Diabetes Linked to High Stress Levels 2
(Date:10/19/2014)... October 19, 2014 Große ... Das Problem dabei ist, dass große Pharmafirmen ... Kompetenz zu teilen. Es war deshalb ... wir uns umso mehr, dass es uns gelungen ... bei Kühlketten aufzuschreiben - mit einem Vorbehalt - ...
(Date:10/17/2014)... Oct. 17, 2014  Hanger, Inc. (NYSE: ... its results of operations for the quarter ended September ... market closes.  A conference call to discuss these results ... Friday, November 7, 2014. Those wishing to participate should ... November 14, 2014 by dialing 1-855-859-2056 and referencing Conference ...
(Date:10/17/2014)... Oct. 17, 2014 Research and ... "Research and Development Prospect of China Dialysis Market, ... Based on the 2013 version, this update ... about dialysis industry and the relevant effect in ... dialysis industry segmentations. Moreover, it analyzes Chinese private-owned ...
Breaking Medicine Technology:Vergleichsbericht zu Pharma-Kühlketten und CRT 2Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3
... UBM Live , a division of UBM Plc (LSE: ... and collocated events will be hosted in Madrid, Spain in ... and outsourced services and logistics, P-MEC for pharmaceutical technology and ... for pharmaceutical packaging needs. The events will run from 9-11 ...
... 26, 2011 OTC Markets Group Inc. ... that provides the world,s largest electronic marketplace for broker-dealers ... Technology Inc. (TSX.V: VRS; OTCQX: VRSEF), a medical ... early detection of cancer, is now trading on the ...
Cached Medicine Technology:CPhI Worldwide, ICSE, P-MEC and InnoPack Announce 2012 Events Location 2CPhI Worldwide, ICSE, P-MEC and InnoPack Announce 2012 Events Location 3Verisante Technology Inc. Joins OTCQX 2
... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
... With its simplified operations, the ... patient, clinic or satellite lab testing. ... offers multi-language software. Built on ... technology, the KX-21N features a completely ...
... Tubes were designed for ease of use, ... capillary blood sample is collected. The wider-diameter ... features an integrated collection scoop and improved ... tubes is available for hematology and chemistry ...
... The Identity pacemaker family, which ... provides clinicians with the most advanced ... AF Suppression algorithm, the first and ... to suppress atrial fibrillation (AF). The ...
Medicine Products: